Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen van Besien

Showing results (41-50 of 241) with videos related to

Pageof 25
Sort By:
Leukemia & Lymphoma|April 22, 2014
To the end of chronic lymphocytic leukemia: what should be the role of allogeneic transplant?Koen van Besien, Richard R Furman
Leukemia & Lymphoma|February 3, 2015
A new "age" for high dose therapy and autologous stem cell transplantAdrienne A Phillips, Koen van Besien
Leukemia & Lymphoma|May 24, 2019
It's not all about the CNS. High dose methotrexate in DLBCLJohn N Allan, Koen Van Besien
Leukemia & Lymphoma|September 29, 2021
Maintenance therapy after allogeneic transplant for acute myeloid leukemia: great expectationsKoen van Besien, Alexandra Gomez-Arteaga
Seminars in Oncology|October 6, 2005
Hematopoietic stem cell transplantation for myelofibrosisKoen van Besien, H Joachim Deeg
Leukemia & Lymphoma|December 11, 2012
Pre-transplant serum ferritin is prognostic but is it useful?Andrew S Artz, Koen van Besien
Leukemia & Lymphoma|August 17, 2017
Earlier may be better: the role of extracorporeal photopheresis (ECP) as prevention of GVHD after allogeneic transplantHannah K Choe, Koen van Besien
Leukemia & Lymphoma|September 7, 2023
Immune reconstitution inflammatory syndrome in a patient with <i>M.haemophilum</i> infection after allogeneic hematopoietic stem cell transplantationMarkus Plate, Jose Jessurun, Koen van Besien
JAMA Oncology|November 5, 2020
Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin LymphomaKoen van Besien, Nina Orfali, Tsiporah Shore
Leukemia & Lymphoma|July 6, 2016
HLA: revisiting an old suspect in the complex pathogenesis of posttransplant lymphoproliferative disordersDaan Dierickx, Ben Sprangers, Koen Van Besien
Pageof 25

Showing results (41-50 of 241) with videos related to

Sort By:
Pageof 25
Leukemia & Lymphoma|April 22, 2014
To the end of chronic lymphocytic leukemia: what should be the role of allogeneic transplant?Koen van Besien, Richard R Furman
Leukemia & Lymphoma|February 3, 2015
A new "age" for high dose therapy and autologous stem cell transplantAdrienne A Phillips, Koen van Besien
Leukemia & Lymphoma|May 24, 2019
It's not all about the CNS. High dose methotrexate in DLBCLJohn N Allan, Koen Van Besien
Leukemia & Lymphoma|September 29, 2021
Maintenance therapy after allogeneic transplant for acute myeloid leukemia: great expectationsKoen van Besien, Alexandra Gomez-Arteaga
Seminars in Oncology|October 6, 2005
Hematopoietic stem cell transplantation for myelofibrosisKoen van Besien, H Joachim Deeg
Leukemia & Lymphoma|December 11, 2012
Pre-transplant serum ferritin is prognostic but is it useful?Andrew S Artz, Koen van Besien
Leukemia & Lymphoma|August 17, 2017
Earlier may be better: the role of extracorporeal photopheresis (ECP) as prevention of GVHD after allogeneic transplantHannah K Choe, Koen van Besien
Leukemia & Lymphoma|September 7, 2023
Immune reconstitution inflammatory syndrome in a patient with <i>M.haemophilum</i> infection after allogeneic hematopoietic stem cell transplantationMarkus Plate, Jose Jessurun, Koen van Besien
JAMA Oncology|November 5, 2020
Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin LymphomaKoen van Besien, Nina Orfali, Tsiporah Shore
Leukemia & Lymphoma|July 6, 2016
HLA: revisiting an old suspect in the complex pathogenesis of posttransplant lymphoproliferative disordersDaan Dierickx, Ben Sprangers, Koen Van Besien
Pageof 25